Skip to content
healthcare.dev

VYXEOS

NDC 68727-745, (daunorubicin and cytarabine) liposome, injection, powder, lyophilized, for suspension, from Jazz Pharmaceuticals, Inc..

Product NDC
68727-745
Status
Listed
Labeler
Jazz Pharmaceuticals, Inc.
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA209401
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68727-745 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CYTARABINE100 mg/20mL
  • DAUNORUBICIN44 mg/20mL

Pharmacologic classes

Anthracycline Topoisomerase Inhibitor [EPC]; Anthracyclines [CS]; Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]; Topoisomerase Inhibitors [MoA]

Package NDCNDC-11Package
68727-745-016872707450120 mL in 1 VIAL (68727-745-01)
68727-745-026872707450240 mL in 1 CARTON (68727-745-02)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7ea701ce-e7d3-4349-a9c2-642a501d45c8
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=68727-745

Use it

Look up 68727-745 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68727-745 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68727-745. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.